Suppr超能文献

为导管原位癌患者选择治疗方法:对南加州大学/凡奈斯预后指数进行微调。

Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index.

作者信息

Silverstein Melvin J, Lagios Michael D

机构信息

Breast Program, Hoag Memorial Hospital Presbyterian, Newport Beach, CA , USA.

出版信息

J Natl Cancer Inst Monogr. 2010;2010(41):193-6. doi: 10.1093/jncimonographs/lgq040.

Abstract

The University of Southern California/Van Nuys Prognostic Index is an algorithm that quantifies five measurable prognostic factors known to be important in predicting local recurrence in conservatively treated patients with ductal carcinoma in situ (tumor size, margin width, nuclear grade, age, and comedonecrosis). With three times as many patients since originally developed, sufficient numbers now exist for analysis by individual scores rather than groups of scores. To achieve a local recurrence rate of less than 20% at 12 years, these data support excision alone for all patients scoring 4, 5, or 6 and patients who score 7 but have margin widths ≥ 3 mm. Excision plus RT achieves the less than 20% local recurrence requirement at 12 years for patients who score 7 and have margins < 3 mm, patients who score 8 and have margins ≥ 3 mm, and for patients who score 9 and have margins ≥ 5 mm. Mastectomy is required for patients who score 8 and have margins < 3 mm, who score 9 and have margins < 5 mm, and for all patients who score 10, 11, or 12 to keep the local recurrence rate less than 20% at 12 years. These recommendations in this article represent substantial changes from those previously published.

摘要

南加州大学/凡奈斯预后指数是一种算法,它量化了五个可测量的预后因素,这些因素在预测经保守治疗的导管原位癌患者的局部复发中很重要(肿瘤大小、切缘宽度、核分级、年龄和粉刺样坏死)。自最初开发以来,患者数量增加了两倍,现在有足够的数量可以按个体分数而非分数组进行分析。为了在12年时使局部复发率低于20%,这些数据支持对所有得分为4、5或6分的患者以及得分为7分但切缘宽度≥3mm的患者仅进行切除。对于得分为7分且切缘<3mm的患者、得分为8分且切缘≥3mm的患者以及得分为9分且切缘≥5mm的患者,切除加放疗可在12年时达到低于20%的局部复发要求。对于得分为8分且切缘<3mm的患者、得分为9分且切缘<5mm的患者以及所有得分为10、11或12分的患者,需要进行乳房切除术,以使12年时的局部复发率低于20%。本文中的这些建议与之前发表的建议有很大变化。

相似文献

3
Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Clin Breast Cancer. 2018 Dec;18(6):441-450.e2. doi: 10.1016/j.clbc.2018.04.002. Epub 2018 Apr 10.
6
The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.
World J Surg Oncol. 2008 Jun 18;6:61. doi: 10.1186/1477-7819-6-61.
10
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.

引用本文的文献

2
Tools to Guide Radiation Oncologists in the Management of DCIS.
Healthcare (Basel). 2024 Apr 6;12(7):795. doi: 10.3390/healthcare12070795.
5
Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician's Dilemma.
Ann Surg Oncol. 2023 Oct;30(11):6281-6283. doi: 10.1245/s10434-023-13691-1. Epub 2023 Jun 6.
6
8
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018.
Breast Care (Basel). 2022 Oct;17(5):486-494. doi: 10.1159/000524564. Epub 2022 Apr 21.
10
Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery.
Cancer Med. 2022 Jul;11(14):2755-2766. doi: 10.1002/cam4.4651. Epub 2022 May 22.

本文引用的文献

1
3
A prognostic index for ductal carcinoma in situ of the breast.
Cancer. 1996 Jun 1;77(11):2267-74. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V.
4
Prognostic classification of breast ductal carcinoma-in-situ.
Lancet. 1995 May 6;345(8958):1154-7. doi: 10.1016/s0140-6736(95)90982-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验